ISSN: ISSN: 2157-7412
Reimbursement dynamics and market access hurdles for orphan drugs in the EU5
Akash Saini
Specific clinical and evolutionary aspects of adenosine deaminase 2 deficiency (DADA2)
Djamel Eddine Ouail,Faycal Bouali, Djamila Si Ahmed,Hassina Ahmane, Meriem Tebbani
Orphan medicines and paediatric drug development
Mette Due Theilade Thomsen
Real world data in the new era of clinical research
Elena Tenti, MSc, PharmD
Primary cutaneous actinomycosis: A first case report from Kurdistan- Iraq
Yassob Sulaiman
Strategy of attention to rare diseases in Catalonia
Roser Francisco,Pilar Magrinya, Josep Torrent,Alex Guarga, Cristina Mallol and Cristina Nadal
The positive effect of SKD plus IOT and HBO2T in the treatment of cancer
Sorush Niknamian,Somayeh Zaminpira
The evolving landscape of pre-approval access to orphan drugs
Stuart Bell